Interestingly, the down‐regulated expression of ALKBH5 and FTO was found to be related to poor overall survival and cancer‐specific survival in renal cell carcinoma, which implied that ALKBH5 and FTO could serve as potential prognostic biomarkers.43 This evidence concerns the gene ALKBH5 and cancer.